Literature DB >> 27565290

Antinociceptive activity of a polysaccharide from the roots of Sophora flavescens.

Ruimei Jia1, Quancheng Li1, Weixi Shen2, Jiuwei Zhang3, Lihong Zheng4, Guonian Wang5.   

Abstract

A polysaccharide (SFWP), with a molecular weight of 51kDa, was successfully purified from the roots of Sophora flavescens and the antinociceptive actions of SFWP were evaluated using acetic acid induced writhing, tail flick, and formalin tests in mice. GC-MS results showed that SFWP had a backbone composed of (1→2)-linked Glc, (1→2,6)-inkedGal and (1→3,6)-inked Man residues, which were terminated with (1→)-inked Xyl and (1→)-inked Ara at O-6 of (1→2,6)-inkedGal and (1→3,6)-inked Man along the main chain, in the ratio of 2.0: 1.02: 1.09: 1.10: 0.98. Data showed that SFWP (100, 200 and 400mg/kg) significantly reduced the number of writhings induced by acetic acid in a dose-dependent manner. However, SFWP did not produce analgesia in tail-flick test. Moreover SFWP strongly attenuated the formalin-induced flinching behaviour in the second phases but not in the first phase in a dose-dependent manner. These results revealed that SFWP could be used safely to attenuate both inflammatory and peripheral neuropathic pain.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antinociceptive activity; Polysaccharide; Sophora flavescens Ait

Mesh:

Substances:

Year:  2016        PMID: 27565290     DOI: 10.1016/j.ijbiomac.2016.08.054

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  2 in total

1.  Selenious-β-lactoglobulin induces the apoptosis of human lung cancer A549 cells via an intrinsic mitochondrial pathway.

Authors:  Guo-Qiang Zheng; Hai-Yu Ji; Shao-Jing Zhang; Juan Yu; An-Jun Liu
Journal:  Cytotechnology       Date:  2018-08-10       Impact factor: 2.058

2.  Sex Difference of Effect of Sophora flavescens on Gut Microbiota in Rats.

Authors:  Xueqing Duan; Xin Xie; Chen Zhu; Zhixuan Duan; Rui Chen; Jun Xu; Qi Zhang; Qi Yu; Weiyi Tian
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-15       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.